Research progress of inhibitors of peptides and peptidomimetic acting on P 53-MDM2 i nte rf ace / 药学实践杂志
Journal of Pharmaceutical Practice
;
(6): 494-497,512, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-790522
ABSTRACT
Tumor diseases have attracted great attention of the society because of the increasing morbidity in recent years .To inhibit the P53-MDM2 interaction has become an important target for design of cancer drug ,and a lot of peptide and small molecule inhibitors have been found with various kinds of drug screening and research tools .This paper summarized the recent progress of the peptide and peptidomimetic inhibitors of P53-MDM2 at home and abroad lately .
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Pharmaceutical Practice
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS